Enterprise Value
637.5M
Cash
318.2M
Avg Qtr Burn
-28.57M
Short % of Float
24.06%
Insider Ownership
29.28%
Institutional Own.
82.30%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DAY101 Details Glioma, Solid tumor/s, Cancer | NDA Submission | |
DAY101 Details Solid tumor/s, Cancer | Phase 2 Interim update |